Home/Filings/4/0001867096-24-000018
4//SEC Filing

Pieper Steven 4

Accession 0001867096-24-000018

CIK 0001867096other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 5:05 PM ET

Size

4.9 KB

Accession

0001867096-24-000018

Insider Transaction Report

Form 4
Period: 2024-01-31
Pieper Steven
See Remarks
Transactions
  • Award

    Common Stock

    2024-01-31+450,0001,626,912 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

Issuer

Xeris Biopharma Holdings, Inc.

CIK 0001867096

Entity typeother

Related Parties

1
  • filerCIK 0001875714

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:05 PM ET
Size
4.9 KB